Improving dexamethasone drug loading and efficacy in treating rheumatoid arthritis via liposome: Focusing on inflammation and molecular mechanisms
Abstract Rheumatoid arthritis (RA) is a chronic autoimmune disease that affects approximately 0.46% of the global population. Conventional therapeutics for RA, including disease‐modifying antirheumatic drugs (DMARDs), nonsteroidal anti‐inflammatory drugs (NSAIDs), and corticosteroids, frequently res...
Saved in:
Main Authors: | Mohammad Yasin Zamanian, Hamidreza Zafari, Maria K. Osminina, Alla A. Skakodub, Raed Fanoukh Aboqader Al‐Aouadi, Maryam Golmohammadi, Nikta Nikbakht, Iman Fatemi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | Animal Models and Experimental Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/ame2.12518 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeted nanoliposomes for precision rheumatoid arthritis therapy: a review on mechanisms and in vivo potential
by: Rushikesh Girase, et al.
Published: (2025-12-01) -
Locally administered liposomal drug depot enhances rheumatoid arthritis treatment by inhibiting inflammation and promoting cartilage repair
by: Zongquan Zhang, et al.
Published: (2025-01-01) -
Optimizing glycerosome formulations via an orthogonal experimental design to enhance transdermal triptolide delivery
by: Zhu Chunyun, et al.
Published: (2022-03-01) -
siRNA therapeutics for effective management of rheumatoid arthritis
by: Vishakha R. Chakole, et al.
Published: (2025-01-01) -
Comparative evaluation of ondansetron, palonosetron, and dexamethasone for antiemetic prophylaxis in cesarean section under spinal anaesthesia
by: Vankudoth Bhaskar, et al.
Published: (2025-02-01)